Sandy Cove Advisors, LLC Sc Pharmaceuticals Inc. Transaction History
Sandy Cove Advisors, LLC
- $224 Million
- Q2 2024
A detailed history of Sandy Cove Advisors, LLC transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Sandy Cove Advisors, LLC holds 10,592 shares of SCPH stock, worth $45,969. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,592
Previous 10,592
-0.0%
Holding current value
$45,969
Previous $53,000
13.21%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding SCPH
# of Institutions
77Shares Held
27.7MCall Options Held
39.2KPut Options Held
2.6K-
Orbimed Advisors LLC San Diego, CA5.56MShares$24.1 Million0.58% of portfolio
-
Rubric Capital Management LP New York, NY3.53MShares$15.3 Million0.45% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.5MShares$15.2 Million5.52% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX2.21MShares$9.57 Million0.04% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$7.68 Million0.0% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $119M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...